IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q3 2019 Holdings

Filed 2019-11-04 | 2 holdings | $97.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Magenta Therapeutics, Inc.COM55910K108$82.2K8,008,20484.1%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$15.6K2,343,15415.9%